biperiden has been researched along with DDPAC in 1 studies
Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gallucci, M | 1 |
Pallucca, C | 1 |
Di Battista, ME | 1 |
Bergamelli, C | 1 |
Fiore, V | 1 |
Boccaletto, F | 1 |
Fiorini, M | 1 |
Perra, D | 1 |
Zanusso, G | 1 |
Fenoglio, C | 1 |
Serpente, M | 1 |
Galimberti, D | 1 |
Bonanni, L | 1 |
1 other study available for biperiden and DDPAC
Article | Year |
---|---|
Anti-Cholinergic Derangement of Cortical Metabolism on 18F-FDG PET in a Patient with Frontotemporal Lobar Degeneration Dementia: A Case of the TREDEM Registry.
Topics: Aged; Biperiden; Cerebral Cortex; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Male; Men | 2020 |